The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs

被引:89
作者
Daniel-Mwambete, K
Torrado, S
Cuesta-Bandera, C
Ponce-Gordo, F
Torrado, JJ
机构
[1] Univ Complutense Madrid, Fac Farm, Dept Farm & Tecnol Farmaceut, E-28040 Madrid, Spain
[2] Univ Complutense Madrid, Fac Farm, Dept Parasitol, E-28040 Madrid, Spain
关键词
solubility; complexation; povidone; bioavailability; solid dispersion;
D O I
10.1016/j.ijpharm.2003.11.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of solubilization by complexation with povidone on the oral bioavailability of three anthelmintic benzimidazole carbamate drugs: mebendazole (MBZ), albendazole (ABZ) and ricobendazole (RBZ), was studied in mice. The following in vitro characteristics of the initial raw materials and the drug-povidone complexes were evaluated: melting point (MP); mean dissolution time (MDT); solubility constants (Cs) in n-octanol, acid (pH 1.2) and neutral (pH 7.4) aqueous media; apparent partition coefficients (P) and capacity factors (k(w)') determined by HPLC. The following in vivo parameters were also evaluated: W AUC(0-infinity), C-max, T-max and MRT. The possible relationship between in vitro characteristics and in vivo parameters was explored and it was found that an increase in solubility, especially in acidic medium, leads to an increase in AUC and C-max and a decrease in T-max. Therefore, dissolution seems to be the absorption limiting step for these drugs. For the in vivo parameters related to the amount of absorbed drug (AUC and C-max), the best correlation was obtained with the in vitro characteristics related to solubility which are Cs, MP and MDT. On the other hand, there were good linear correlations between T-max, which is an in vivo parameter related to the rate of drug absorption, and the lipophilia/hydrophilia (log P and log k(w)') relation-parameters. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 23 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]   Preparation and characterization of albendazole β-cyclodextrin complexes [J].
Castillo, JA ;
Palomo-Canales, J ;
Garcia, JJ ;
Lastres, JL ;
Bolas, F ;
Torrado, JJ .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (12) :1241-1248
[3]  
CHIBA Y, 1991, CHEM PHARM BULL, V39, P2158, DOI 10.1248/cpb.39.2158
[4]   Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin [J].
Evrard, B ;
Chiap, P ;
DeTullio, P ;
Ghalmi, F ;
Piel, G ;
Van Hees, T ;
Crommen, J ;
Losson, B ;
Delattre, L .
JOURNAL OF CONTROLLED RELEASE, 2002, 85 (1-3) :45-50
[5]  
Florence AT, 1998, PHYSICOCHEMICAL PRIN
[6]   Albendazole generics - A comparative in vitro study [J].
Galia, E ;
Horton, J ;
Dressman, JB .
PHARMACEUTICAL RESEARCH, 1999, 16 (12) :1871-1875
[7]   SIMULTANEOUS PHARMACOKINETIC MODELING OF A DRUG AND 2 METABOLITES - APPLICATION TO ALBENDAZOLE IN SHEEP [J].
GALTIER, P ;
ALVINERIE, M ;
STEIMER, JL ;
FRANCHETEAU, P ;
PLUSQUELLEC, Y ;
HOUIN, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (01) :3-10
[8]   Quantitative determination of albendazole and its main metabolites in plasma [J].
Garcia, JJ ;
Bolás-Fernández, F ;
Torrado, JJ .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 723 (1-2) :265-271
[9]   Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole [J].
Garcia, JJ ;
Bolás, F ;
Torrado, JJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (02) :351-358
[10]   BIOAVAILABILITY ESTIMATION BY REVERSED-PHASE LIQUID-CHROMATOGRAPHY - HIGH BONDING DENSITY C-18 PHASES FOR MODELING BIOPARTITIONING PROCESSES [J].
HSIEH, MM ;
DORSEY, JG .
ANALYTICAL CHEMISTRY, 1995, 67 (01) :48-57